Adimmune Corporation(TW:4142)
NT$16.60-0.20 (-1.19%)
TW:4142
Adimmune Corporation financials statements
NT$16.60
At close:-0.20 (-1.19%)
Adimmune Corporation (4142) Income Statement
Adimmune Corporation Income Statement
Last quarter (Q2 2026), Adimmune Corporation's total revenue was NT$66.76M, a decrease of 38.54% from the same quarter last year. In Q2, Adimmune Corporation's net income was NT$-160.23M. See Adimmune Corporation’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 1.40B | NT$ 1.56B | NT$ 1.79B | NT$ 2.25B | NT$ 1.64B | |
| NT$ 288.49M | NT$ 448.06M | NT$ 410.94M | NT$ 891.08M | NT$ 464.14M | |
| NT$ 648.04M | NT$ 747.15M | NT$ 1.13B | NT$ 792.53M | NT$ 670.95M | |
| Depreciation and Amortization | NT$ 214.86M | NT$ 215.70M | NT$ 224.13M | NT$ 259.32M | NT$ 225.91M |
| NT$ -144.69M | NT$ -84.30M | NT$ -512.43M | NT$ 438.12M | NT$ 254.89M | |
| NT$ -359.55M | NT$ -299.09M | NT$ -722.75M | NT$ 98.55M | NT$ -54.09M | |
| NT$ 29.78M | NT$ -37.40M | NT$ -47.23M | NT$ 62.65M | NT$ 68.38M | |
| NT$ -329.77M | NT$ -336.49M | NT$ -769.98M | NT$ 156.22M | NT$ 14.29M | |
| NT$ -239.89M | NT$ -242.75M | NT$ -639.89M | NT$ 290.98M | NT$ 43.07M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ -0.57 | NT$ -0.58 | NT$ -1.52 | NT$ 0.68 | NT$ 0.10 |
| Diluted EPS | NT$ -0.57 | NT$ -0.58 | NT$ -1.52 | NT$ 0.68 | NT$ 0.10 |
| Weighted Average Shares Outstanding | 420.86M | 421.51M | 420.98M | 427.23M | 429.51M |
| Weighted Average Shares Outstanding (Diluted) | 420.86M | 421.51M | 421.51M | 427.68M | 429.60M |
Currency in TWD

